IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Introduction
Diabetes has emerged as one of the most serious and common chronic diseases of our times, causing life threatening, disabling and costly complications, and reducing life expectancy. [1] The global prevalence of diabetes had reached pandemic proportions with the 9th edition of the IDF reporting a prevalence of 9% (463 million adults) in 2019. The rising prevalence of diabetes has been attributed principally to the ageing of populations. However, decreasing mortality among those with diabetes due to improving medical care as well as increases in diabetes incidence in some countries resulting from increasing prevalence of diabetes risk factors, especially obesity, are also important drivers of higher prevalence. [2], [3]
The aim of the 10th edition of the IDF Diabetes Atlas is to provide updated estimates and projections of diabetes prevalence as well as health expenditure due to diabetes at national, regional, and global levels.
Section snippets
Methods
The IDF Diabetes Atlas methods have been previously described in detail. [4] This study complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) recommendations (see Supplementary material for checklist). [5] The following sections provide a brief summary, and includes any changes introduced by the 10th edition.
For the 10th edition of the IDF Diabetes Atlas, the list of countries and territories was re-evaluated based on the UN list of countries [6] (United
Study sources
The 2019–2020 literature review identified 13,570 articles of which 153 met the pre-defined inclusion criteria (Fig. 1) and proceeded to data extraction. After contacting authors or organisations from 94 studies to obtain detailed age- and sex-stratified data and further details about methods, a total of 106 new studies met our inclusion criteria and were added into the IDF Diabetes Atlas database. The grey literature search (including data from the IDF Regional offices and WHO STEPwise approach
Discussion
The 10th edition IDF Diabetes Atlas estimates that in 2021 there are 537 million people living with diabetes worldwide. Overall, the global prevalence of diabetes is now estimated to be over 10%. Among income groups, the highest prevalence was observed in middle-income countries. Compared to the previous 9th IDF Diabetes Atlas edition, we report an overall 12.9% increase in diabetes prevalence, with prevalence increasing in many world regions
Future projections suggest that by 2045 the absolute
Conclusion
The 10th edition of the IDF Diabetes Atlas suggests that in 2021 more than 1 in 10 adults now have diabetes globally and that the number of people with diabetes will continue to expand rapidly in the future. As our projections only consider demographic changes in populations relating to ageing and urbanisation, and not changes in risk factor prevalence or in survival, it is likely that our projected increases over time are conservative. Prevalence is predicted to increase the most among
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
We would like to thank all those who have supported the production of the IDF Diabetes Atlas, 10th edition, by providing additional diabetes data, where needed. We would like to thank Prof Agus Salim, Baker Heart and Diabetes Institute Australia for reviewing the statistical methodology employed in this edition.
Funding
The 10th edition of the IDF Diabetes Atlas was supported by an educational grant from the Pfizer-MSD Alliance, with the additional support of Sanofi and Novo Nordisk.
References (23)
- et al.
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Lancet
(2020) - et al.
Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
Lancet
(2016) - et al.
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Diabetes Res Clin Pract.
(2018) - et al.
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition
Diabetes Res Clin Pract.
(2019) - et al.
Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings
Lancet Diabetes Endocrinol.
(2021) - Heald AH, Stedman M, Davies M, Livingston M, Alshames R, Lunt M, et al. Estimating life years lost to diabetes:...
- et al.
Trends in incidence of total or type 2 diabetes: systematic review
BMJ
(2019) - Guariguata L, Whiting D, Weil C, Unwin N. The International Diabetes Federation diabetes atlas methodology for...
- United Nations. Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019,...
- Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation;...
Artefactual inflation of type 2 diabetes prevalence in WHO STEP surveys
Trop Med Int Health.
Cited by (3067)
Centella asiatica mitigates the detrimental effects of Bisphenol-A (BPA) on pancreatic islets
2024, Scientific ReportsTrends in antidiabetic drug use and expenditure in public hospitals in Northwest China, 2012-21: a case study of Gansu Province
2024, BMC Health Services Research
- 1
Denotes equal recognition for the first and last authorship positions.